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To examine the association between apparent diffusion coefficient (ADC), cellularity and 
Ki-67 index in mucinous breast carcinoma (MBC) compared with invasive carcinoma of 
no special type (NST). ADC’s ability to identify lesions with highly-proliferating MBC 
was also examined. 
Materials and Methods 
Pathologically confirmed MBCs (mucinous group, n=18) and NSTs (control group, 
n=18) were retrospectively analyzed. ADC was calculated from signal intensity of 
diffusion weighted imaging at b values of 0 and 1000sec/mm2. Ki-67 index and 
cellularity were histopathologically evaluated. The mucinous group was classified into 
high Ki-67 mucinous group (Ki-67 index ≥ 14%, highly-proliferating) and low Ki-67 
mucinous group. 
Results 
In the mucinous group, minimum ADC (ADCmin) showed inverse correlation with 
cellularity (r=-0.802, p=<0.0001) and Ki-67 index (r=-0.825, p=<0.0001). In the control 
group, ADCmin showed inverse correlation with cellularity (r=-0.537 p=0.022), but no 
correlation with Ki-67 index (r=0.035, p=0.892). ADCmin of high Ki-67 mucinous group 
was significantly lower than that of low Ki-67 mucinous group (p=0.005).  
Conclusion 
This study demonstrated an inverse correlation between ADC and Ki-67 index in MBC 
and the ability of ADC to identify highly-proliferating MBC. Considering that ADC can 
evaluate whole lesions noninvasively, ADC may be a promising non-invasive surrogate 
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Diffusion weighted MR imaging (DWI) is well recognized as a useful non-contrast MR 
sequence for breast carcinoma(1). In various organs, including the breast, an inverse 
correlation between tumor cellularity and apparent diffusion coefficient (ADC; a 
quantitative parameter in DWI) is generally observed (2,3). Several DWI studies have 
demonstrated significantly lower ADC for breast carcinomas than for benign breast 
lesions (2-4).  
 In the clinical practice of breast cancer management, risk stratification is as important as 
distinguishing between malignant and benign. Since uncontrolled proliferation is a key 
feature of the progression of malignancy, immunohistochemical assessment of the 
nuclear antigen Ki-67 is now widely used as a tool for breast cancer stratification (5,6). 
The nuclear antigen Ki-67 is detectable in cells at all phases of the cell cycle except the 
G0 phase (7), and the Ki-67 index (the percentage of cells with Ki-67 positive nuclear 
immunostaining) is a measure of tumor proliferation. There is growing interest in the use 
of Ki-67 index as a pharmacodynamic biomarker of treatment efficacy in samples taken 
before, during, and after neoadjuvant therapy, particularly neoadjuvant endocrine therapy 
(6).  
 In previous reports (8,9), neither invasive carcinomas (various types) nor invasive ductal 
carcinomas of not otherwise specified type (equivalent to “invasive carcinoma of no 
special type” in the newest WHO classification (10)) showed significant correlation 
between ADC and Ki-67 index. Considering the inverse correlation between ADC and 
tumor cellularity (2,3), these results may imply that there is no correlation between 
cellularity and Ki-67 index in invasive carcinoma of no special type (NST).  




other types of breast carcinoma, because MBC presents higher ADC than benign breast 
lesions and other malignant breast tumors due to abundant mucin and low cellularity, as 
reported by Woodhams et al.(11). Better prognostic factors have been reported in pure 
MBC than in mixed MBC(12,13), and in hypocellular type pure MBC than in cellular 
type (14), which suggested an association between cellularity and prognostic factors in 
MBC. Considering these special features of MBC, we hypothesized that ADC is 
associated with Ki-67 index in MBC.  
 The aims of this study were 1) to examine the association between ADC, cellularity and 
Ki-67 index in MBC compared to luminal-type NST, and 2) to evaluate the potential of 
ADC to distinguish between highly proliferating and low proliferating MBC. 
 
MATERIALS AND METHODS  
Patients 
 Approval for this study was obtained from the Institutional Review Board of our 
institution, and informed consent was waived due to retrospective study design. Between 
September 2008 and March 2012, 17 females (mean age=58.6 years, age range=39-76 
years) were pathologically diagnosed with mucinous breast carcinoma (hypocellular type 
of pure MBC, 11; cellular type of pure MBC, 5; mixed MBC, 1) at our institution. As a 
control group, 17 female patients (mean age=60.5 years, age range=43-80 years) 
diagnosed with luminal-type NST during the same period of time were selected, matched 
for histological grade, MR scan date (within two months) and MR scanner type (3.0 T/ 
1.5 T). Every patient underwent breast MRI scan and pathological evaluation by core 
needle biopsy (CNB) or surgery at intervals of two months maximum. Patients receiving 




MRI scans and pathological evaluations at the same period of therapies (pre- / post-). 
 Seventeen patients with MBC (14 without neoadjuvant therapy, 2 post NAE, 1 pre & 
post NAE) provided 18 lesions (mucinous group: hypocellular type of pure MBC, 11; 
cellular type of pure MBC, 5; mixed MBC, 2). Seventeen patients with luminal-type NST 
(14 without neoadjuvant therapy, 2 post NAC, 1pre & post NAC) provided 18 lesions 
(control group). 
 
MRI Acquisition  
 Between September 2008 and March 2012, breast MRI was performed with a 3.0/1.5 T 
scanner (MAGNETOM Trio/Avant, A Tim System, Siemens AG) with 16/4ch breast coil. 
Routinely, T2-weighted, T1-weighted, Diffusion-weighted and fat-suppressed 
T1-weighted dynamic contrast enhancing images were obtained. Bilateral breast 
diffusion-weighted images were obtained using the following parameters: axial 
orientation, single shot-EPI, TR/TE 7000/62 ms, FOV 330×160 mm, matrix 166×80, 
thickness 3 mm, NEX 3, 48 slices. Other parameters were as follows: T2-weighted 
images; 6000/85-87ms, thickness 2.5mm / T1-weighted images; 3D-Gradient echo 
4.87/2.45, thickness 1.25mm / fat-suppressed T1-weighted dynamic contrast enhancing 
images; pre- and post- (three times at 0–1, 1–2 and 5–6 min after gadolinium injection) 
contrast whole breast axial scanning in high temporal resolution for 1 min (3D-VIBE: 
R/TE 3.8/1.48 ms, FA 15 and FOV 330 mm×330 mm, matrix 448×461, 2.5 mm thickness, 
60 slices), post contrast (at 2–5 min after gadolinium injection) whole breast coronal 
scanning in high-resolution (3D-VIBE: TR/TE 4.2/1.5 ms, FA 15, FOV 330 mm×330 
mm, matrix 448×412, thickness 0.8 mm, 176 slices). Infused gadolinium contrast 




(Omniscan, Daiichi-Sankyo Inc., Tokyo, Japan) at a dose of 0.2 ml/kg power injected at a 
speed of 2.0 ml/s and flushed with 20 ml of saline at the same rate. 
 
Image Analysis 
 Breast carcinoma lesions were detected and analyzed by diffusion-weighted images in 
association with T2-weighted, T1-weighted and dynamic contrast enhancing images in 
order to accurately identify the lesions.  
 ADC values were calculated using the algorithm presented by the following equation: 
ADC=[1/(b2-b1)]×In [S1/S2], where S1 and S2 are the signal intensities in the region of 
interest (ROI) obtained by two gradient factors, b1 and b2 (b1= 0 sec/mm2, b2=1000 
sec/mm2). Inside the breast carcinoma lesions, placing as many 3×3 mm circle ROIs as 
possible without overlapping areas, the average ADC (ADCave) and the minimum ADC 
(ADCmin) values were obtained. At this time, cystic or necrotic areas were carefully 
excluded by checking T2-&T1-weighted and dynamic contrast enhancing images. These 
radiological evaluations were made by a breast radiologist (SK; 15 years of experience). 
 
Pathological Analysis 
 Specimens were resected surgically and fixed overnight in 10% neutralized buffered 
formalin, then cut into 5 mm slices, and embedded in paraffin. Paraffin-embedded 
samples were serially sliced into 4 μm slices, and deparaffined by xylene. Serial sections 
were stained with hematoxylin-eosin (HE), and immunostained using anti-estrogen 
receptor (ER) antibody and anti-Ki-67 antibody (DAKO Cytomation, Glostrup, 
Denmark). Pathological diagnoses were made by breast pathologists (TRK with 13 years 




 The average of the estrogen receptor (ER) positivity was 95.7% (range 70-100%) in the 
mucinous group and 98.3% (range 90-100%) in the control group. 
 
Ki-67 Index 
 The Ki-67 index was assessed microscopically. All tumor cell nuclei with homogenous 
granular staining, multiple speckled staining, or nucleolar staining were considered 
positively stained regardless of intensity, while any cytoplasmic immunoreactivity was 
considered non-specific, and hence not taken into consideration. Scoring was performed 
in the areas with highest number of positive nuclei (hot spot) within the tumor. The Ki-67 
index was expressed as the percentage of Ki-67 positive malignant cells in 1,000 
malignant cells assessed under high power magnification (×400). 
 In the context of the St. Gallen consensus 2013 (15), we classified the mucinous group 
into “low Ki-67 mucinous group (Ki-67 index; <14%)” and “high Ki-67 mucinous group 
(Ki-67 index; ≥14%)”. 
 
Analysis of Tumor Cellularity 
 Pathologists initially selected the areas with highest number of Ki-67 positive nuclei (hot 
spot), its adjacent area, and lowest number of Ki-67 positive nuclei (cold spot) in each 
specimen stained by Ki-67. At 20-fold magnification, these three fields of view (FOVs: 
1.6×1.2mm) were digitally photographed and saved as image files. HE- and ER-stained 
slides were likewise photographed at the same FOVs. In this way, 9 image files were 
saved for each specimen. From these image files, the tumor cellularity was analyzed 
according to the methods of previous studies (2,11). 




positive tumor cell nuclei were selected using the range selection tool, and their RGB 
thresholds were computed. Adjusting the RGB thresholds of each image according to the 
computed values, only ER-positive tumor cell nuclei were visualized. Each ER stained 
image was converted to black & white mode and the binarized image was obtained. Using 
histogram, composition area ratio of ER positive tumor cell nuclei (=[counts of black 
pixels / total pixels]×100) was calculated. Multiplying this ratio by 100/ER positivity, 
tumor cellularity was calculated. Three values were calculated for each specimen from 
three FOVs. Considering the correspondence to Ki-67 index, the maximum value among 
the three was chosen as the tumor cellularity. 
 
Statistical Analysis 
 Statistical analysis was performed with JMP10 (SAS institute). Correlation between 
ADCmin/ave, tumor cellularity and Ki-67 index was evaluated using Pearson’s 
correlation coefficient. ADC values of the high Ki-67 mucinous group and low Ki-67 
mucinous group were compared using Mann-Whitney test. A P value of less than 0.05 
was considered statistically significant. 
 
RESULTS 
Correlation between ADCmin/ave, tumor cellularity and Ki-67 index is summarized in 
Table 1. In the mucinous group, ADCmin showed an inverse correlation with cellularity 
(r=-0.802, p<0.0001) (Figure1a) and with Ki-67 index (r=-0.825, p<0.0001) (Figure1b). 
Correlation between cellularity and Ki-67 index was also significant (r=0.633, p=0.005). 
In the control group, ADCmin showed an inverse correlation with cellularity (r=-0.537, 




no significant correlation between cellularity and Ki-67 (r=0.032, p=0.899) in this group.  
 ADCave showed correlation patterns similar to ADCmin in both the mucinous and 
control group, but correlations tended to be weaker with ADCave than with ADCmin 
(Table1).  
When comparing the high and low Ki-67 mucinous groups, ADCmin of the high Ki-67 
mucinous group was significantly lower than that of the low Ki-67 mucinous group 
(p=0.005) (Figure2a). The high Ki-67 mucinous group can be identified with a sensitivity 
of 100% and a specificity of 93% by using the cut-off value of ADCmin=1.27 ×10-3mm2 
/sec. 
 Among three different types of MBC, the mixed MBC and the cellular type of pure MBC 
showed lower ADCmin than the hypocellular type of pure MBC (Figure2b). 
 Microphotographs of specimens (HE staining and Ki-67 immunohistochemical staining) 
from two representative MBC lesions, and the corresponding MR images (ADCmap), are 
shown in Figure3 and 4. The hypocellular type of pure MBC lesion shows low cellularity, 
low Ki-67 index and high ADCmin (Figure 3), while the mixed MBC lesion shows high 
cellularity, high Ki-67 index and low ADCmin (Figure 4). 
 
DISCUSSION 
 We demonstrate an inverse correlation between ADC and Ki-67 index in MBC. The high 
Ki-67 mucinous group presented significantly lower ADCmin than the low Ki-67 
mucinous group and can be classified with the cut-off value of ADCmin=1.27 
×10-3mm2/sec. These results suggest the potential of ADC as a non-invasive surrogate 
biomarker for Ki-67 index. It should be emphasized that ADC can be used to evaluate the 




sampled by biopsy.   
 MBC is generally known for its relatively favorable prognosis, but MBC contains 
subtypes with aggressive progression and prognosis (16). Therefore, evaluating the 
cellular proliferative potential is crucial in the appropriate treatment of MBC. Ki-67 
index is currently of interest as a pharmacodynamic biomarker of treatment efficacy in 
samples taken before, during, and after neoadjuvant therapy, particularly neoadjuvant 
endocrine therapy. Our results suggest that ADC can be used for this purpose in MBC.  
 In the control group, ADCmin showed an inverse correlation with cellularity, but no 
significant correlation with Ki-67 index. This is different from the results in the mucinous 
group, where ADCmin and cellularity showed significant correlation with Ki-67 index. 
These contrasting results may be explained by considering the relation between 
cellularity and Ki-67 index from a histopathological viewpoint. NST morphologically 
vary considerably and may contain extremely variable stromal components (e.g. foci of 
elastosis, focal necrosis) (10). As cellularity is affected by the ratio between the area for 
the tumor cells and the surrounding stroma, it is speculated that cellularity is affected by 
the presence of stromal components such as central necrosis or fibrosis (CNF). 
Considering that high Ki-67 index is associated with CNF in invasive ductal breast 
carcinoma (17) and lymph node-negative breast cancer (18), breast cancer with high 
Ki-67 index may not necessarily have high cellularity, which is compatible with the result 
in the control group where no correlation was seen between cellularity and Ki-67 index. 
In contrast, the correlation between cellularity and Ki-67 index seen in the mucinous 
group may imply that MBC, characterized by proliferation of nests of cells floating in 
lakes of mucin (16), has less stromal components that affect cellularity.  




previously described. MBC can be classified into 3 subtypes: hypocellular type of pure 
MBC (major type), cellular type of pure MBC, and mixed MBC (containing 
non-mucinous “cellular” components consisting of infiltrating carcinoma without 
extracellular mucin). Anan et al(13) reported that incidences of lymphatic vessel invasion 
and nodal involvement were lower in pure MBC than in mixed MBC. Fentiman et al(12) 
reported that pure MBC had significantly better relapse-free and overall survival than 
mixed MBC. These reports suggest the importance of differentiating mixed MBC from 
pure MBC. Also, differentiation of the cellular type of pure MBC from the hypocellular 
type may be important according to Clayton(14), who demonstrated good correlation 
between low cellularity and survival in pure MBC. In our study, the mixed MBC and 
cellular type of pure MBC presented significantly lower ADCmin than the hypocellular 
type of pure MBC. MBC has been excluded from several reported studies in the potential 
use of ADC for breast cancer detection because of its high ADC mimicking benign 
lesions (11,19). Our results suggest ADC may have the ability for detecting MBC with 
the poorer prognosis. If we can obtain the same result on larger sample size in the future, 
it might be helpful for the detection and risk stratification of MBC. 
The above discussion further indicates a wider application of ADC as a biomarker of 
cell proliferation in additional situations. ADC is particularly associated with Ki-67 index 
in MBC because cellularity is associated with tumor aggressiveness (12-14). If we can 
identify the specific situations where cellularity is associated with cell proliferation (e.g. 
among specific subtype or during chemotherapy), ADC may be used as a biomarker of 
cell proliferation in such situations, not limited to MBC. 
Another interesting result from the current study is that ADCmin is a better surrogate 




an inverse correlation with Ki-67 index in the mucinous group, ADCmin showed a 
stronger correlation with Ki-67 index than ADCave. Considering that Ki-67 index is 
calculated using the “hot spot” counts in the pathology specimen, it is reasonable that 
ADCmin, reflecting information from presumably the most “cellular” area, is a better 
marker for Ki-67 index than ADCave. 
A few limitations of this study should be noted. Firstly, luminal-type NST lesions 
(average ER positivity 98.3%) were selected as a control group because all lesions in the 
mucinous group were luminal-type (average ER positivity 95.7%), and cellularity was 
evaluated using ER stained images. Therefore, these study results cannot be applied to 
HER2 type and triple negative type. Retrospective study design and small sample size are 
other limitations, though these were inevitable because of the low frequency of MBC.  
 In conclusion, our analysis demonstrated 1) the inverse correlation between ADC and 
Ki-67 index in MBC, and 2) the ability of ADC to classify highly proliferating MBC from 
those that are low proliferating. Considering the advantage of ADC in evaluating whole 
the lesion non-invasively, in contrast to Ki-67 index which only evaluates part of the 
lesion, ADC may be a promising non-invasive surrogate marker for Ki-67 index in the 
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Correlation between ADCmin/ave, cellularity and Ki-67 index in mucinous group and 
control group; ADCave shows correlation patterns similar to ADCmin, but with larger 
p-values and weaker correlation than ADCmin 
  ADCmin    ADCave 
  r P-value    r P-value 
Mucinous group         
     ADC vs. Cellularity -0.802 <0.0001 -0.788 0.0001  
     ADC vs. Ki-67 index -0.825 <0.0001 -0.695 0.001  
     Cellularity vs. Ki-67 index 0.633 0.005 0.633 0.005  
Control group     
     ADC vs. Cellularity -0.537 0.022 -0.412 0.090  
     ADC vs. Ki-67 index 0.035 0.892 0.005 0.985  
     Cellularity vs. Ki-67 index 0.032 0.899 0.032 0.899  
ADC; apparent diffusion coefficient 
ADCmin; the minimum ADC 
ADCave; the average ADC 







Correlations between ADCmin, cellularity and Ki-67 index in mucinous group  
a). An inverse correlation is indicated between ADCmin and cellularity (r=-0.802, 
p<0.0001). 




Distribution of ADCmin in mucinous group 
a). High Ki-67 mucinous group (Ki-67 index; ≥14%) shows significantly lower ADCmin 
than low Ki-67 mucinous group (p=0.005; Mann-Whitney test). 
b). Mixed MBC and cellular type of pure MBC show lower ADCmin than hypocellular 
type of pure MBC.  
 
Figure3 
Representative case of pure MBC (hypocellular type) 
a). HE-stained specimen (×40); shows clusters of carcinoma cells floating in lakes of 
mucin, representing hypocellular nature. 
b). Ki-67 immunohistochemical stained specimen (×40); shows nuclei of tumor cells 
positively stained (brown) (Ki-67 index=7.4%). 







Representative case of mixed MBC 
a). HE-stained specimen (×40); shows large clusters of cells along with mucus reflecting 
higher cellularity. 
b). Ki-67 immunohistochemical-stained specimen (×40); shows relatively large number 
of positively-stained nuclei (brown) (Ki-67 index=34.7%). 
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